Verrica Pharmaceuticals Inc (VRCA)

Dec 21, 2024

Verrica Pharmaceuticals Reports Progress on Molluscum Treatment and Pipeline Development - MSN

Dec 21, 2024

Dec 20, 2024

Verrica reports rise in YCANTH applicator units in Q4 By Investing.com - Investing.com South Africa

Dec 20, 2024

Dec 20, 2024

Verrica reports rise in YCANTH applicator units in Q4 - Investing.com

Dec 20, 2024

Dec 20, 2024

Verrica Provides Business and Operational Update - GlobeNewswire

Dec 20, 2024

Dec 20, 2024

Verrica Pharma's YCANTH Sales Surge in Q4; Plans Game-Changing Single Applicator Launch for 2025 - StockTitan

Dec 20, 2024

Dec 20, 2024

GLP-1 Receptor Agonist Market Is Booming Worldwide 2024-2031:Verrica Pharmaceuticals,AbbVie Inc,Glenmark - EIN News

Dec 20, 2024

Dec 18, 2024

Verition Fund Management LLC Acquires New Holdings in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) - Defense World

Dec 18, 2024

Dec 16, 2024

Verrica Pharmaceuticals stock hits 52-week low at $0.7 By Investing.com - Investing.com Canada

Dec 16, 2024

Dec 16, 2024

Verrica Pharmaceuticals stock hits 52-week low at $0.7 - Investing.com

Dec 16, 2024

Dec 14, 2024

Verrica Pharmaceuticals' SWOT analysis: stock faces headwinds amid strategic shift - Investing.com

Dec 14, 2024

Dec 14, 2024

Verrica Pharmaceuticals' SWOT analysis: stock faces headwinds amid strategic shift By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 14, 2024

Verrica Pharmaceuticals Inc. Appoints David Zawitz as Chief Operating Officer - Marketscreener.com

Dec 14, 2024

Dec 13, 2024

GLP-1 Receptor Agonist Market Is Booming Worldwide 2024-2031: Novan Inc., Verrica Pharmaceuticals, AbbVie - EIN News

Dec 13, 2024

Dec 13, 2024

Verrica Pharmaceuticals Grants Stock Option to New COO David Zawitz - MSN

Dec 13, 2024

Dec 09, 2024

PERCEPTIVE ADVISORS LLC Increases Stake in Verrica Pharmaceutica - GuruFocus.com

Dec 09, 2024

Dec 09, 2024

Verrica Pharmaceuticals appoints new COO By Investing.com - Investing.com South Africa

Dec 09, 2024

Dec 09, 2024

Verrica Pharmaceuticals appoints new COO - Investing.com India

Dec 09, 2024

Dec 09, 2024

Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 09, 2024

Dec 09, 2024

Verrica Pharmaceuticals Appoints New Chief Operating Officer - TipRanks

Dec 09, 2024

Dec 07, 2024

Verrica's partner Torii seeks Japan NDA for skin treatment By Investing.com - Investing.com Canada

Dec 07, 2024

Dec 07, 2024

New Drug Application Submitted in Japan for Verrica Pharmaceuticals’ TO-208 - MyChesCo

Dec 07, 2024

Dec 06, 2024

Verrica's partner Torii seeks Japan NDA for skin treatment - Investing.com India

Dec 06, 2024

Dec 06, 2024

Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan - The Manila Times

Dec 06, 2024

Dec 06, 2024

Verrica Pharmaceuticals Announces that Development Partner - GlobeNewswire

Dec 06, 2024

Dec 06, 2024

Verrica's Partner Files NDA in Japan for Breakthrough Molluscum Treatment, Targeting 1.6M Patient Market - StockTitan

Dec 06, 2024

Nov 28, 2024

Verrica Pharmaceuticals (FRA:1NE) Debt-to-Revenue : N/A (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

Nov 27, 2024

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation - MSN

Nov 27, 2024

Nov 27, 2024

Common Warts Pipeline Insights 2024: Therapies, Clinical - openPR

Nov 27, 2024

Nov 26, 2024

West Chester-based Verrica Pharmaceuticals Expects to Raise $42 Million in Public Stock Offering - VISTA.Today

Nov 26, 2024

Nov 22, 2024

Latham & Watkins Advises on Verrica Pharmaceuticals Inc.’s Public Offering - Latham & Watkins LLP

Nov 22, 2024

Nov 22, 2024

Chester County firm expects to raise $42M after trimming staff and naming new CEO - The Business Journals

Nov 22, 2024

Nov 21, 2024

Verrica Pharmaceuticals stock dips after pricing $42M securities offering - MSN

Nov 21, 2024

Nov 21, 2024

Verrica Prices of $42 Million Public Offering - citybiz

Nov 21, 2024

Nov 21, 2024

VRCAVerrica Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024

Nov 21, 2024

Verrica Announces Pricing of $42.0 Million Public Offering - GlobeNewswire

Nov 21, 2024

Nov 21, 2024

Verrica Pharmaceuticals Raises $42M Through Public Offering of Shares and Warrants | VRCA Stock News - StockTitan

Nov 21, 2024

Nov 20, 2024

Verrica Pharmaceuticals announces proposed public offering - MSN

Nov 20, 2024

Nov 20, 2024

Form 424B5 Verrica Pharmaceuticals - StreetInsider.com

Nov 20, 2024

Nov 20, 2024

Verrica Announces Proposed Public Offering - The Manila Times

Nov 20, 2024

Nov 20, 2024

Verrica Pharmaceuticals Announces Public Offering of Stock and Warrants with Jefferies | VRCA Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Verrica Pharmaceuticals Reports Q3 2024 Financials and Restructuring Plans - MSN

Nov 20, 2024

Nov 15, 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Nov 15, 2024

Nov 13, 2024

Verrica Pharmaceuticals' SWOT analysis: navigating challenges in dermatology stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Verrica Pharmaceuticals' SWOT analysis: navigating challenges in dermatology stock By Investing.com - Investing.com UK

Nov 13, 2024

Nov 12, 2024

Q1 Earnings Forecast for VRCA Issued By HC Wainwright - Defense World

Nov 12, 2024

Nov 10, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Cut to “Neutral” at HC Wainwright - Defense World

Nov 10, 2024

Nov 10, 2024

Verrica downgraded to sector perform by RBC Capital - MSN

Nov 10, 2024

Nov 09, 2024

Verrica Pharmaceuticals’ (VRCA) Hold Rating Reaffirmed at Needham & Company LLC - Defense World

Nov 09, 2024

Nov 08, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 08, 2024